This study attempts to compare the prevalence of persuasive and informative appeals found in direct-to-consumer (DTC) ads of prescription drugs in consumer magazines. A content analysis of DTC ads in a stratified randomized sample of magazines published from 1995 to 2000 identified the use of 10 types of persuasive appeals and 12 types of informative appeals. The average ad employed the use of 6.24 informative appeals and 3. 13 persuasive appeals. DTC ads in magazines with a predominately male readership were found to contain a greater number of persuasive appeals than ads in other magazines. While the products most frequently advertised were for chronic nonlife-threatening conditions, a panel of pharmacists evaluated the majority of these products as having a high degree of clinical usefulness. Despite significant differences in the prevalence of certain types of appeals among ads for different products, the balance of persuasive and informative appeals did not vary considerably among them. Ads for drugs judged to be more specious in clinical usefulness did not employ the use of additional persuasive appeals and were found to be just as informative as ads for other drugs.
PenickTM. New trends in direct-to-consumer advertising: The Actigall® campaign. J Pharm Market Manag.1993; 7(3):9–107.
2.
PerriMNelsonAAJr.An exploratory analysis of consumer recognition of direct-to-consumer advertising of prescription medications. J Health Care Market.1987;7(1):9–17.
3.
LiptonC. Consumer advertising and pharmaceuticals: A happy marriage?J Pharm Market Manag.1993;7(2)23–28.
4.
WintersP. Prescription drug ads up: Information-hungry boomers to fuel continued growth. Advertise Age.1993; 64:37.
5.
KeithA. Information matters: The consumer as the integrated health care system. In ManningRLMasiaNA (eds.). Prescription Drug Advertising: Empowering Consumer Through Information.New York, NY: Pfizer, Inc.; 2001.
6.
PintoMBPintoJKBarberJC. The impact of pharmaceutical direct advertising: Opportunities and obstructions. Health Market Quart.1998;15(4):89–101.
7.
HuntM. Direct-to-consumer advertising of prescription drugs. Presented at the National Health Policy Forum, April 1998, The George Washington University, Washington, DC.
8.
DesselleSPAparasuR. Attitudinal dimensions that determine pharmacists’ decisions to support DTCA of prescription medications. Drug Inf J.2000; 34:103–114.
9.
The Internet Revolution. In GiorgianniSJ (ed.). The Pfizer Journal, E-Health Care, The Internet Information Revolution.New York, NY: Impact Communications; 2000:4–7.
10.
Smith Barney Research.The New Women's Movement: Women's Healthcare.New York, NY: Smith Barney Research; April 1997.
11.
LevyS. Study finds strong consumer awareness of DTC Rx ads. Drug Topics.2000;13:47.
12.
ParkerBJDeleneLM. Direct-to-consumer prescription drug advertising: content analysis and public policy implications. J Pharm Market Manag.1998;12(4):27–42.
13.
RosenthalMBBerndtERDonohueJMFrankRGEpsteinAM. Promotion of prescription drugs to consumers. N Engl J Med.2002;346(7): 498–505.
14.
Trends in direct-to-consumer advertising of prescription drugs.Kaiser Family Foundation. Available at http://www.kff.org/content/2002/3162/. Accessed November 29, 2002.
15.
HefflerSLevitKSmithSSmithCCowanCLazenH. Health spending growth up in 1999: faster growth expected in the future. Health Aff.2001;20:193–203.
MaddoxLMKatsanisLP. Direct-to-consumer advertising of prescription drugs in Canada: Its potential effect on patient-physician interaction. J Pharm Market Manag.1997:12(1)1–21.
19.
KemperDWMettlerM. A consumer-empowered response to direct-to-consumer advertising of prescription drugs. Manag Care Quar.2002; 10(2):52–54.
20.
Anon.Americans at risk from self-medication, survey reveals. Am J Health-Syst Pharm.1997; 54: 2664–2666.
21.
RothMS. Patterns in direct-to-consumer prescription drug print advertising and their public policy implications. J Pub Policy Market.1996;15(1):63–75.
22.
CraigRP. The patient as a partner in prescribing: direct-to-consumer advertising. J Man Care Pharm.1998;4(1):15–19.
SullivanD. Patient Understanding of the Brief Summary Information in Direct-to-Consumer Advertising of Prescription Drugs. Presented at the American Pharmaceutical Association Annual Meeting, March 15–19, 2002, Philadelphia, PA.
25.
CadyPSLarsonLN. Brief summary and the believability of consumer prescription drug advertising. J Pharm Market Manag.1989;3(4): 65–72.
26.
SmithDL. Consumers call for clarity in DTC ads. Pharm Exec.1999; 19(11):116.
27.
ConlanMF. Many consumer ill-informed about Rxs, says AARP. Drug Topics.2000; 11:20.
28.
SumpraditNAscioneFBagozziR. A cross-media content analysis of direct-to-consumer prescription drug advertising (DTCA). Presented at the American Pharmaceutical Association Annual Meeting, March 15–19, 2002, Philadelphia, PA.
29.
PintoMB. On the nature and properties of appeals used in direct-to-consumer advertising of prescription drugs. Psych Rep.2000; 86: 597–607.
30.
WoloshinSSchwartzLMTremmelJWelchHG. Direct-to-consumer advertisements for prescription drugs: What are Americans being sold?Lancet.2000;358:1141–1146.
31.
WilkesMSBellRAKravitzRL. Direct-to-consumer prescription drug advertising: Trends, impact, and implications. Health Aff.2000; 19:110–128.
32.
National Institute for Health Care Management.Washington, DC: Prescription Drugs and Mass Media Advertising.Washington, DC: National Institute for Health Care Management; September 2000.
33.
ManningRKeithA The economics of direct-to-consumer advertising of prescription drugs. In ManningRLMasiaNA (eds.). Prescription Drug Advertising: Empowering Consumers Through Information.New York, NY: Pfizer, Inc., 2001.
34.
SheffetMJKoppSW. Advertising prescription drugs to the public: Headache or relief?J Public Policy Market.1990;9:42–61.
35.
Choices II Database version 6.0c. New York, NY: Simmons Market Research Bureau; August 1999.
36.
AdayLA. Deciding how Many will be in a Sample. Designing and Conducting Health Surveys: A Comprehensive Guide.San Francisco, CA: Jossey-Bass; 1996.
37.
HoogS. Over-the-counter drug advertising: Argumentation or persuasion. J Pharm Market Manag.1994;9(2): 69–91.
38.
SPSS Base 10.0User's Guide.Chicago, IL: SPSS, Inc.; 1999.
39.
RustRTCooilB. Reliability measures for qualitative data: Theory and implications. J Market Res.1994;(Feb): 1–14.
40.
StoneTRWarrenWEStevensRE. Segmenting the mental health care market. J Health Care Market.1990;10(1):65–69.
41.
ChristiansenTPAscioneFJBagozziRP. Understanding how elderly patients process drug information: A test of information processing. Pharm Res.1997;14:1589–96.
42.
BradleyLRZitoJM. Direct-to-consumer prescription drug advertising. Med Care.1997;35(1):86–92.
43.
ChoiYThorsonE. Memory for factual, emotional, and balanced ads under two instructional sets. In FletcherAD (ed.). Proceedings of the 1983 Conference of the American Academy of Advertising.Knoxville, TN: University of Tennessee: 1983.
44.
GoldbergMEGornGJ. Happy and sad TV programs: how they affect reactions to commercials. J Consum Res.1987;14:387–403.
45.
PageTJThorsonEHeideMP. The memory impact of commercials varying in emotional appeal and product involvement. In AgresSJEdellJADubitskyTM (eds.) Emotion in Advertising.New York, NY: Quorum Books; 1990.
46.
UnwinS. Customized communications-a concept for service advertising. Advertise Quart.1975;44:28–30.
47.
Albers-MillerNDStaffordMR. An international analysis of emotional and rational appeals in services vs goods advertising. J Consum Market.1999;16(1):42–57.
48.
CutlerBDJavalgiRG. Analysis of print ad features: Services versus products. J Advertise Res.1993;33(2):62–70.
49.
DubeLChattopadhyayALetarteA. Should advertising appeals match the basis of consumers’ attitudes?J Advertise Res.1996;36(6):82–89.
50.
BiswasAOlsenJECarletV. A comparison of print advertisements from the United States and France. J Advertise. 1992;21(4):73–81.
51.
SrivastavaTSchoenbachlerDD. An examination of the information and thematic content of consumer print advertising in India. J Int Consum Market.1999;12(2):63–85.
52.
SciulliLMTaianiV. Advertising content for the global audience: A research proposal. Competitive Rev.2001;11(2):39–47.
53.
TurleyLWKelleySW. A comparison of advertising content: Business to business versus consumer services. J Advertise.1997;26(4):39–48.
54.
SmithMCViscontiJA. Appeals used in prescription drug advertising. Hosp Pharm.1968;3(2):5–13.
55.
WechslerJ. Advertising under attack. Pharm Exec.2000;20(7):26–34.
56.
ShahMSHolmesERDesselleSP. The use of persuasion in print DTC advertisements of prescription drugs: A content analysis of leading consumer magazines from 1995–2000. J Pharma Market Manag.2003;15(3):23–43.
